AAAAAA
Results:
1-7
|
Results: 7
Authors:
Cheson, BD
Bennett, JM
Kantarjian, H
Schiffer, CA
Nimer, SD
Lowenberg, B
Stone, RM
Mittelman, M
Sanz, GF
Wijermans, PW
Greenberg, PL
Citation: Bd. Cheson et al., Response: Myelodysplastic syndromes standardized response criteria: further definition, BLOOD, 98(6), 2001, pp. 1985-1985
Authors:
Cheson, BD
Bennett, JM
Greenberg, PL
Citation: Bd. Cheson et al., Clarifications of response criteria in myelodysplastic syndrome - Response, BLOOD, 97(10), 2001, pp. 3322-3322
Authors:
Talpaz, M
Berman, E
Clift, RA
Copelan, EA
Emanuel, PD
Erba, HP
Glenn, MJ
Greenberg, PL
Jones, RJ
O'Brien, S
Saba, HI
Schilder, R
Snyder, DS
Soiffer, RJ
Tallman, MS
Wetzler, M
Ravandi-Kashani, F
Kantarjian, H
Talpaz, M
Citation: M. Talpaz et al., NCCN Practice Guidelines for chronic myelogenous leukemia, ONCOLOGY-NY, 14(11A), 2000, pp. 229-240
Authors:
Cheson, BD
Bennett, JM
Kantarjian, H
Pinto, A
Schiffer, CA
Nimer, SD
Lowenberg, B
Beran, M
de Witte, TM
Stone, RM
Mittelman, M
Sanz, GF
Wijermans, PW
Gore, S
Greenberg, PL
Citation: Bd. Cheson et al., Report of an international working group to standardize response criteria for myelodysplastic syndromes, BLOOD, 96(12), 2000, pp. 3671-3674
Authors:
Greenberg, PL
Citation: Pl. Greenberg, An apology, J HEMATH ST, 8(4), 1999, pp. 333-333
Authors:
Advani, R
Saba, HI
Tallman, MS
Rowe, JM
Wiernik, PH
Ramek, J
Dugan, K
Lum, B
Villena, J
Davis, E
Paietta, E
Litchman, M
Sikic, BI
Greenberg, PL
Citation: R. Advani et al., Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC833 (Valspodar), BLOOD, 93(3), 1999, pp. 787-795
Authors:
Greenberg, PL
Citation: Pl. Greenberg, Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment, LEUK RES, 22(12), 1998, pp. 1123-1136
Risultati:
1-7
|